MUCOSAL MELANOMA

Clinical trials for MUCOSAL MELANOMA explained in plain language.

Never miss a new study

Get alerted when new MUCOSAL MELANOMA trials appear

Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 11 Not yet recruiting 4 Not yet finished but already full! 8 Completed 5 Terminated 1

Can an immune checkpoint blocker outperform interferon in keeping mucosal melanoma at bay?

Disease control Terminated

This phase II trial tests whether toripalimab, an anti-PD-1 antibody, can prevent mucosal melanoma from returning after surgical removal better than high-dose interferon. Adults aged 18 to 75 whose melanoma was completely removed and who have not had prior adjuvant therapy are el…

Matched conditions: MUCOSAL MELANOMA

Phase: PHASE2 • Sponsor: Shanghai Junshi Bioscience Co., Ltd. • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC

MUCOSAL MELANOMA

Get alerted when new MUCOSAL MELANOMA trials appear

Can an immune checkpoint blocker outperform interferon in keeping mucosal melanoma at bay?